Search results
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks via Yahoo Finance· 1 day agoEli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and...
S&P (SPX) today: The index is up 11.90% YTD
USA Today· 2 hours agoThe S&P 500 opened today at 5,310.07. Within 30 minutes of trading, the benchmark index rose by 3.31 points, or 0.06%, to 5,313.38. Year to date, the...
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks via Yahoo Finance· 3 hours agoHere we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK),...
10 Health Care Stocks With Whale Alerts In Today's Session - Boston Scientific (NYSE:BSX), Biomarin...
Benzinga· 23 hours agoThis particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.9K , with a price of $266.0 ...
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo Finance· 3 hours agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 7 hours agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 5 days agoThat may not seem like much, but AbbVie pays a hefty dividend that yields a robust 3.8% at the...
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 2 days agoThe Swiss-based pharmaceutical company has strong financials, pays a high dividend, and is always in...
The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory
InvestorPlace· 3 days agoHigh interest rates are here to stay. Federal Reserve Chairman Jerome Powell said the fight against...
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 6 days agoA phase IIb study is ongoing in patients with moderate-to-severe atopic dermatitis...Zacks Rank #4...